-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Sigilon Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2023.
- Sigilon Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$71K, a 77.1% increase year-over-year.
- Sigilon Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $595K.
- Sigilon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $105K.
- Sigilon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.68M, a 14.8% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)